Mainz Biomed N.V.
MYNZ
$3.07
-$0.15-4.66%
NASDAQ
| 12/31/2024 | 12/31/2023 | 09/30/2022 | |||
|---|---|---|---|---|---|
| Revenue | -13.13% | 11.12% | 81.25% | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -13.13% | 11.12% | 81.25% | ||
| Cost of Revenue | -26.63% | -49.04% | -31.70% | ||
| Gross Profit | -5.05% | 271.07% | 135.09% | ||
| SG&A Expenses | -33.66% | -7.49% | 24.44% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | -33.99% | -20.71% | 47.66% | ||
| Operating Income | 34.67% | 21.44% | -47.10% | ||
| Income Before Tax | -2.51% | 36.70% | -20.62% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -2.51% | 36.70% | -20.62% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -2.51% | 36.70% | -20.62% | ||
| EBIT | 34.67% | 21.44% | -47.10% | ||
| EBITDA | 34.76% | 24.47% | -45.70% | ||
| EPS Basic | 64.49% | 49.71% | 26.64% | ||
| Normalized Basic EPS | 73.98% | 42.83% | 10.91% | ||
| EPS Diluted | 64.49% | 49.71% | 26.64% | ||
| Normalized Diluted EPS | 73.98% | 42.83% | 10.91% | ||
| Average Basic Shares Outstanding | 188.70% | 25.88% | 64.42% | ||
| Average Diluted Shares Outstanding | 188.70% | 25.88% | 64.42% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||